{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:25:55Z","timestamp":1791285955488,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1053\/gast.2002.36021","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T19:52:28Z","timestamp":1033501948000},"page":"1090-1098","source":"Crossref","is-referenced-by-count":80,"title":["p16INK4a Promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma"],"prefix":"10.1053","volume":"123","author":[{"given":"Makiko","family":"Taniai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Burgart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Gores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/gast.2002.36021_bib1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000658-199101000-00004","article-title":"Cholangiocarcinoma complicating primary sclerosing cholangitis","volume":"213","author":"Rosen","year":"1991","journal-title":"Ann Surg"},{"key":"10.1053\/gast.2002.36021_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0039-6060(05)80078-9","article-title":"Primary sclerosing cholangitis: liver transplantation or biliary surgery","volume":"117","author":"Farges","year":"1995","journal-title":"Surgery"},{"key":"10.1053\/gast.2002.36021_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510270201","article-title":"Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study","volume":"27","author":"Bergquist","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/gast.2002.36021_bib4","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers","volume":"341","author":"de Groen","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/gast.2002.36021_bib5","first-page":"184","article-title":"Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism","volume":"60","author":"Jaiswal","year":"2000","journal-title":"Cancer Res"},{"key":"10.1053\/gast.2002.36021_bib6","first-page":"6388","article-title":"Human Ogg1, a protein involved in the repair of 8-oxoguanine, is inhibited by nitric oxide","volume":"61","author":"Jaiswal","year":"2001","journal-title":"Cancer Res"},{"key":"10.1053\/gast.2002.36021_bib7","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0021-9258(18)48474-8","article-title":"8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G\u2192 T and A\u2192C substitutions","volume":"267","author":"Cheng","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1053\/gast.2002.36021_bib8","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1021\/bi00482a011","article-title":"Mechanistic studies of ionizing radiation and oxidative mutagenesis: genetic effects of a single 8-hydroxyguanine (7-hydro-8-oxoguanine) residue inserted at a unique site in a viral genome","volume":"29","author":"Wood","year":"1990","journal-title":"Biochemistry"},{"key":"10.1053\/gast.2002.36021_bib9","doi-asserted-by":"crossref","first-page":"G626","DOI":"10.1152\/ajpgi.2001.281.3.G626","article-title":"Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis","volume":"281","author":"Jaiswal","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1053\/gast.2002.36021_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1383-5742(00)00022-3","article-title":"Oxidative base damage to DNA: specificity of base excision repair enzymes","volume":"462","author":"Cadet","year":"2000","journal-title":"Mutat Res"},{"key":"10.1053\/gast.2002.36021_bib11","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/gast.2001.20875","article-title":"Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes","volume":"120","author":"Jaiswal","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2002.36021_bib12","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1021\/tx9600311","article-title":"DNA damage by nitric oxide","volume":"9","author":"Tamir","year":"1996","journal-title":"Chem Res Toxicol"},{"key":"10.1053\/gast.2002.36021_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1126\/science.274.5289.998","article-title":"Laser capture microdissection","volume":"274","author":"Emmert-Buck","year":"1996","journal-title":"Science"},{"key":"10.1053\/gast.2002.36021_bib14","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.278.5342.1481","article-title":"Laser capture microdissection: molecular analysis of tissue","volume":"278","author":"Bonner","year":"1997","journal-title":"Science"},{"key":"10.1053\/gast.2002.36021_bib15","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S0168-9525(98)01489-9","article-title":"Laser-capture microdissection: opening the microscopic frontier to molecular analysis","volume":"14","author":"Simone","year":"1998","journal-title":"Trends Genet"},{"key":"10.1053\/gast.2002.36021_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0092-8674(00)81079-X","article-title":"Role of the INK4a locus in tumor suppression and cell mortality","volume":"85","author":"Serrano","year":"1996","journal-title":"Cell"},{"key":"10.1053\/gast.2002.36021_bib17","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsre.1999.5615","article-title":"Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma","volume":"84","author":"Ahrendt","year":"1999","journal-title":"J Surg Res"},{"key":"10.1053\/gast.2002.36021_bib18","first-page":"2995","article-title":"A novel p16INK4A transcript","volume":"55","author":"Mao","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/gast.2002.36021_bib19","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0092-8674(95)90214-7","article-title":"Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest","volume":"83","author":"Quelle","year":"1995","journal-title":"Cell"},{"key":"10.1053\/gast.2002.36021_bib20","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","article-title":"Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF","volume":"91","author":"Kamijo","year":"1997","journal-title":"Cell"},{"key":"10.1053\/gast.2002.36021_bib21","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0092-8674(93)90636-5","article-title":"Mammalian G1 cyclins","volume":"73","author":"Sherr","year":"1993","journal-title":"Cell"},{"key":"10.1053\/gast.2002.36021_bib22","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"10.1053\/gast.2002.36021_bib23","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/carcin\/21.5.865","article-title":"The INK4a\/ARF locus in murine tumorigenesis","volume":"21","author":"Serrano","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1053\/gast.2002.36021_bib24","first-page":"545","article-title":"Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia","volume":"147","author":"Cordon-Cardo","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1053\/gast.2002.36021_bib25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0092-8674(00)81400-2","article-title":"The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53","volume":"92","author":"Pomerantz","year":"1998","journal-title":"Cell"},{"key":"10.1053\/gast.2002.36021_bib26","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1101\/gad.12.19.2984","article-title":"Tumor surveillance via the ARF-p53 pathway","volume":"12","author":"Sherr","year":"1998","journal-title":"Genes Dev"},{"key":"10.1053\/gast.2002.36021_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.47.5.721","article-title":"Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver","volume":"47","author":"Tannapfel","year":"2000","journal-title":"Gut"},{"key":"10.1053\/gast.2002.36021_bib28","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/ijc.1639","article-title":"Inactivation of the INK4a\/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines","volume":"97","author":"Caca","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1053\/gast.2002.36021_bib29","first-page":"2756","article-title":"Mutations of p16Ink4\/CDKN2 and p15Ink4B\/MTS2 genes in biliary tract cancers","volume":"55","author":"Yoshida","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/gast.2002.36021_bib30","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/368753a0","article-title":"Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers","volume":"368","author":"Nobori","year":"1994","journal-title":"Nature"},{"key":"10.1053\/gast.2002.36021_bib31","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.8153634","article-title":"A cell cycle regulator potentially involved in genesis of many tumor types","volume":"264","author":"Kamb","year":"1994","journal-title":"Science"},{"key":"10.1053\/gast.2002.36021_bib32","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"10.1053\/gast.2002.36021_bib33","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1200\/JCO.1998.16.3.1197","article-title":"Role of the p16 tumor suppressor gene in cancer","volume":"16","author":"Liggett","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/gast.2002.36021_bib34","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nm0795-686","article-title":"5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16\/CDKN2\/MTS1 in human cancers","volume":"1","author":"Merlo","year":"1995","journal-title":"Nat Med"},{"key":"10.1053\/gast.2002.36021_bib35","first-page":"4531","article-title":"Methylation of the 5' CpG island of the p16\/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing","volume":"55","author":"Gonzalez-Zulueta","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/gast.2002.36021_bib36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0065-230X(08)60352-8","article-title":"Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer","volume":"68","author":"Hall","year":"1996","journal-title":"Adv Cancer Res"},{"key":"10.1053\/gast.2002.36021_bib37","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ng0196-97","article-title":"Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma","volume":"12","author":"Zuo","year":"1996","journal-title":"Nat Genet"},{"key":"10.1053\/gast.2002.36021_bib38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/ng1095-210","article-title":"Frequency of homozygous deletion at p16\/CDKN2 in primary human tumours","volume":"11","author":"Cairns","year":"1995","journal-title":"Nat Genet"},{"key":"10.1053\/gast.2002.36021_bib39","first-page":"1137","article-title":"Deletion and mutation analyses of the P16\/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas","volume":"56","author":"Huang","year":"1996","journal-title":"Cancer Res"},{"key":"10.1053\/gast.2002.36021_bib40","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/(SICI)1097-0215(19961220)69:6<466::AID-IJC8>3.0.CO;2-2","article-title":"Inactivation of p16\/CDKN2 and p15\/MTS2 genes in different histological types and clinical stages of primary ovarian tumors","volume":"69","author":"Ichikawa","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1053\/gast.2002.36021_bib41","first-page":"4525","article-title":"Inactivation of the CDKN2\/p16\/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers","volume":"55","author":"Herman","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/gast.2002.36021_bib42","first-page":"1767","article-title":"Methylation, a major mechanism of p16\/CDKN2 gene inactivation in head and neck squamous carcinoma","volume":"151","author":"El Naggar","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1053\/gast.2002.36021_bib43","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/1097-0142(20000701)89:1<60::AID-CNCR9>3.0.CO;2-3","article-title":"p16 is a major inactivation target in hepatocellular carcinoma","volume":"89","author":"Jin","year":"2000","journal-title":"Cancer"},{"key":"10.1053\/gast.2002.36021_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0016-5085(99)70137-X","article-title":"p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma","volume":"116","author":"Matsuda","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/gast.2002.36021_bib45","doi-asserted-by":"crossref","first-page":"38610","DOI":"10.1074\/jbc.M105300200","article-title":"The bile acid glycochenodeoxycholate induces trail-receptor 2\/DR5 expression and apoptosis","volume":"276","author":"Higuchi","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1053\/gast.2002.36021_bib46","doi-asserted-by":"crossref","first-page":"20210","DOI":"10.1074\/jbc.M909992199","article-title":"The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade","volume":"275","author":"Rust","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/gast.2002.36021_bib47","first-page":"6006","article-title":"Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2\/multiple tumor suppressor gene 1 (CDKN2\/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression","volume":"55","author":"Geradts","year":"1995","journal-title":"Cancer Res"},{"key":"10.1053\/gast.2002.36021_bib48","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/gcc.1170","article-title":"Mutation analysis of the CDKN2A promoter in Australian melanoma families","volume":"32","author":"Pollock","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1053\/gast.2002.36021_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0092-8674(01)00486-X","article-title":"Parsing Ink4a\/Arf: \u201cpure\u201d p16-null mice","volume":"106","author":"Sherr","year":"2001","journal-title":"Cell"},{"key":"10.1053\/gast.2002.36021_bib50","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35092592","article-title":"Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis","volume":"413","author":"Sharpless","year":"2001","journal-title":"Nature"},{"key":"10.1053\/gast.2002.36021_bib51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/35092584","article-title":"Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice","volume":"413","author":"Krimpenfort","year":"2001","journal-title":"Nature"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508502002147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508502002147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T12:01:27Z","timestamp":1622203287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508502002147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0016508502002147"],"URL":"https:\/\/doi.org\/10.1053\/gast.2002.36021","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}